End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,500 KRW | -2.06% | -3.06% | +7.55% |
12/03 | JVM Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | JVM Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.23 for the current year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.55% | 243M | D | ||
+12.15% | 227B | B | ||
+14.90% | 197B | B- | ||
+18.22% | 141B | B- | ||
+29.15% | 110B | A- | ||
+0.53% | 64.15B | A- | ||
+16.92% | 53.72B | B+ | ||
+6.33% | 51.75B | B+ | ||
+10.93% | 45.2B | A | ||
+5.87% | 37.37B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- A054950 Stock
- Ratings JVM Co., Ltd.